爱美医疗 FOLD 深 沪
等待开盘 11-11 09:30:00 美东时间
9.00
+0.130
+1.47%
华盛通- 最 高9.01
- 今 开8.93
- 成交量 366.13万股
- 最 低 8.83
- 昨 收 8.87
- 总市值 27.72亿
- 52周最高 10.355
- 市盈率 静 --
- 换手率 1.19%
- 52周最低 5.51
- 委 比 -1.13%
- 总股本 3.08亿
- 历史最高 25.39
- 量 比 0.52
- 振 幅 2.03%
- 历史最低 1.765
- 每 手 1
- 风险率 1.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
Amicus Therapeutics announced that its management will participate in two upcoming investor conferences in November. They will present at the 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL, on November 10, and the Jefferies Global Healthcare Conference in London, UK, on November 18. A live audio webcast of each presentation will be available via the investors section of the Amicus Therapeutics corporate website at [link]. Amicus ...
10-31 11:00
Fold To Release Third Quarter 2025 Results November 10th
Fold Holdings Inc., a bitcoin financial services company, will host its third-quarter earnings conference call on November 10, 2025, at 5:00 PM Eastern Time. Participants can join via live webcast or by dialing in after registering through the provided links. The call details, including dial-in number and passcode, will be emailed upon registration. Fold, known for its innovative bitcoin financial tools, is at the forefront of integrating bitcoin...
10-27 12:30
美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
09-19 09:18
This CSX Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-18 19:23
Needham Upgrades Amicus Therapeutics to Buy, Announces $14 Price Target
Needham analyst Gil Blum upgrades Amicus Therapeutics (NASDAQ:FOLD) from Hold to Buy and announces $14 price target.
09-18 18:00
Amicus Therapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
09-18 17:57
Analysts Offer Insights on Healthcare Companies: Amicus (FOLD) and Protara Therapeutics (TARA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-17 16:50
Amicus Therapeutics Reports 4-Year Muscle Function And Biomarker Data From PROPEL Study Of Cipaglucosidase Alfa + Miglustat In Late-Onset Pompe Disease
Amicus Therapeutics (NASDAQ:FOLD), today announced the presentation of new 4-year muscle function, muscle strength and biomarker endpoints from the PROPEL open-label extension (OLE) study of cipaglucosidase alfa-atga +
09-08 21:05
